Rang	Name	Position
1	Ms. Catherine E. Owen Adams	CEO & Director
2	Mr. Mark C. Schneyer	Executive VP & CFO
3	Ms. Jennifer J. Rhodes J.D.	Executive VP, Chief Legal Officer & Secretary
4	Dr. Elizabeth H. Z. Thompson Ph.D.	Executive VP and Head of Research & Development
5	Mr. Thomas Andrew Garner	Executive VP & Chief Commercial Officer
6	Mr. Scott Cenci	Senior VP, Chief Information & Data Officer
7	Mr. Albert S. Kildani	Senior Vice President of Investor Relations & Corporate Communications
8	Mr. Carl Segerstrom	Chief People Officer
9	Mr. James K. Kihara	Senior Vice President of Finance
10	Ms. Allyson McMillan-Youngblood	Senior Vice President of Rare Disease Franchise

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	Baker Bros Advisors LP	24,90%	1,19 Mrd. USD
2	BlackRock Inc	12,51%	0,60 Mrd. USD
3	Vanguard Portfolio Management, LLC	5,03%	0,24 Mrd. USD
4	State Street Corp	4,84%	0,23 Mrd. USD
5	RTW INVESTMENTS, LLC	4,15%	0,20 Mrd. USD
6	Vanguard Capital Management, LLC	3,29%	0,16 Mrd. USD
7	Dimensional Fund Advisors, Inc.	2,14%	0,10 Mrd. USD
8	Geode Capital Management, LLC	2,01%	0,10 Mrd. USD
9	Palo Alto Investors, LLC	1,66%	0,08 Mrd. USD
10	Point72 Asset Management, L.P.	1,50%	0,07 Mrd. USD
11	BRAIDWELL LP	1,43%	0,07 Mrd. USD
12	Citadel Advisors Llc	1,27%	0,06 Mrd. USD
13	Pictet Asset Manangement SA	1,15%	0,06 Mrd. USD
14	Renaissance Technologies Corp	1,00%	0,05 Mrd. USD
15	D. E. Shaw & Co LP	0,99%	0,05 Mrd. USD
16	NORGES BANK	0,94%	0,05 Mrd. USD
17	Arrowstreet Capital Limited Partnership	0,91%	0,04 Mrd. USD
18	The Goldman Sachs Group Inc	0,90%	0,04 Mrd. USD
19	Bank of America Corp	0,90%	0,04 Mrd. USD
20	Frazier Life Sciences Management, L.P.	0,83%	0,04 Mrd. USD